Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
IMRX
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
52w high -48.8%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
immuneering
nasdaq
trading
last
fourth
high
rating
compared
cancer
period
after
nyse
price
phase
data
previous
upgraded
announced
trial
patients
IMRX
Immuneering Corporation Class A Common Stock
Stonvex
StonvexStonvexStonvexStonvex